🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/07/2018 60,02 60,53 59,94 60,52 +1,16% 0,99% 9.931.058
23/07/2018 59,70 59,90 59,65 59,82 +0,27% 0,43% 7.266.413
20/07/2018 59,22 59,68 59,17 59,66 +0,02% 0,85% 7.204.686
19/07/2018 59,87 60,06 59,40 59,65 -0,68% 1,10% 7.631.641
18/07/2018 59,73 60,10 59,51 60,06 +0,66% 0,97% 6.645.578
17/07/2018 59,67 59,93 59,60 59,67 -0,10% 0,56% 5.292.086
16/07/2018 60,05 60,07 59,48 59,72 -0,48% 0,99% 4.729.938
13/07/2018 59,42 60,15 59,40 60,01 +0,37% 1,27% 7.705.106
12/07/2018 59,58 59,96 59,29 59,79 +1,23% 1,12% 8.424.453
11/07/2018 59,29 59,35 58,77 59,06 -0,64% 0,98% 6.055.344
10/07/2018 59,53 59,76 59,27 59,45 +0,45% 0,83% 11.266.524
09/07/2018 59,60 59,82 59,16 59,18 -0,29% 1,10% 8.724.600
06/07/2018 58,97 59,65 58,96 59,35 +0,91% 1,17% 8.543.191
05/07/2018 58,59 59,12 58,29 58,82 +1,53% 1,42% 9.517.098
03/07/2018 57,96 58,49 57,78 57,93 +0,41% 1,23% 5.106.590
02/07/2018 57,78 57,79 57,18 57,69 -0,40% 1,06% 9.546.337
29/06/2018 57,76 58,65 57,59 57,92 +0,66% 1,85% 14.956.951
28/06/2018 57,36 57,97 57,24 57,54 +0,70% 1,26% 10.691.591
27/06/2018 57,92 58,28 57,06 57,14 -1,38% 2,11% 10.948.770
26/06/2018 58,04 58,23 57,83 57,94 -0,59% 0,67% 12.571.913
25/06/2018 58,60 58,80 57,86 58,28 -0,63% 1,60% 11.057.238
22/06/2018 58,47 59,08 58,42 58,65 +0,47% 1,14% 12.885.998
21/06/2018 58,46 58,46 58,02 58,38 -0,16% 0,75% 9.336.527
20/06/2018 58,26 58,66 58,01 58,47 +0,41% 1,13% 12.757.094
19/06/2018 57,87 58,50 57,85 58,23 +0,07% 1,12% 10.501.589
18/06/2018 58,54 58,55 57,81 58,20 -1,68% 1,26% 9.990.270
15/06/2018 58,77 59,26 58,42 59,19 +0,76% 1,43% 17.246.517
14/06/2018 59,23 59,52 58,42 58,74 -1,65% 1,87% 12.528.211
13/06/2018 59,70 60,08 59,49 59,72 +0,24% 0,97% 9.873.732
12/06/2018 59,51 59,74 59,17 59,58 +0,18% 0,96% 8.308.230